Weight Loss Drugs

Musk In The Rearview: Linda Yaccarino Puts X Behind Her To Become Tom Brady's Boss

Novo Nordisk, Starfighters Space, D-Wave Quantum, Sidus Space And ZIM Integrated Shipping: Why These 5 Stocks Are On Investors' Radars Today

McDonald's Q3 Preview: Report Shows Visitor Slump — Can Value Meals, Monopoly Help Guidance?

Novo Nordisk, Starfighters Space, D-Wave Quantum, Sidus Space And ZIM Integrated Shipping: Why These 5 Stocks Are On Investors' Radars Today

McDonald's Q3 Preview: Report Shows Visitor Slump — Can Value Meals, Monopoly Help Guidance?

Novo Nordisk Poised For UNH-Style Comeback: New Data & AI Boost Signal Reversal

FDA Flags Eli Lilly's Weight-Loss Drug Video For Misleading Claims

Novo Nordisk Poised For UNH-Style Comeback: New Data & AI Boost Signal Reversal

FDA Flags Eli Lilly's Weight-Loss Drug Video For Misleading Claims

Ozempic Is The New Botox And Big Pharma Is Printing Billions

From Elon's X To Weight-Loss Rx: Linda Yaccarino's 'Milestone Day' With Aon

Weight Loss Drugs Recent News

HIMS Crashes On Novo GLP-1 Fallout: Buy The Dip Or Bail?

Telehealth company Hims & Hers (HIMS) saw a 34% stock drop after Novo Nordisk (NVO) ended their relationship. Investors must decide if it's a buying opportunity or a warning sign for the industry.

Zepbound Put Eli Lilly On Top — Now Its Next Big Move Could Supercharge The Stock

Eli Lilly continues to dominate the obesity market with Zepbound and Orforglipron, leading JPMorgan to see it as a top pick with strong growth potential.

McDonald's Just Got Hammered By Weight-Loss Drugs — Twice

McDonald's faces a potential decline in sales due to the weight loss medications. Other fast-food chains like Domino's and KFC are also at risk, while Taco Bell and Chipotle are better positioned.

Veru's Enobosarm Shows Muscle In Wegovy Combo Trial

Veru reports strong safety and efficacy for enobosarm added to semaglutide, showing reduced functional decline and muscle loss in older adults.

Weight Loss Drugs Soar While Global Obesity Rates Climb, To Hit 50% Of Adults By 2050 Says New Report

A global study shows obesity rates predicted to climb. Are weight loss drugs not doing enough or not available in enough countries?

Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst

JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive clinical data insights.

Musk Tests Mounjaro, Ozempic, Wegovy: Which Weight-Loss Drug Won Him Over?

Elon Musk sparked conversation about weight-loss drugs and side effects with a Christmas social media post.

Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance

Amgen's new obesity drug, MariTide, shows promise against giants Eli Lilly and Novo Nordisk, but faces tough competition in a $100B market.

Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum

Analysts are concerned about Viking's ability to compete in the lucrative obesity drug market, dominated by Eli Lilly and Novo Nordisk.

Hims & Hers Health Stock Is Trading Lower Wednesday: Here's Why

Hims & Hers Health shares are falling Thursday following an FDA update listing Novo Nordisk diabetes drug Ozempic and weight-loss drug Wegovy as available, signaling possible supply stability. Here's what you need to know.

Eli Lilly Q3 Earnings On Deck: Stock Split Rumors Heat Up With Weight Loss Gains (CORRECTED)

Eli Lilly reports Q3 earnings on Wednesday. Stock up 58% in past year, potential to split to attract investors in growing weight loss market.

Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains?

Viking Therapeutics (VKTX) set to report Q3 earnings amid high expectations, thanks to promising weight-loss drug candidate. Stock up 240% YTD.

Criminal Networks Cash In On Demand For Weight Loss Drugs, Authorities Say

Counterfeit and diverted weight loss drugs like Ozempic and Mounjaro are flooding international markets, posing serious health risks. Authorities are cracking down on illegal shipments as pharmaceutical companies fight back against counterfeiters.

Eli Lilly Stock Soars In 2024 On Weight Loss Drug Success, Now The Company Wants Medical Records Of Copycat Treatments

To fight off compounding pharmacies, Eli Lilly wants access to medical records of patients who used copycat products.

Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern

Criminals distribute fake Ozempic by forging batch numbers. Novo Nordisk suspects one source in global counterfeiting operation. Other drugs also affected.

Weight-Loss Giant Novo Nordisk Tumbles To 200-Day Average Support: 'Weakness Could Be Buying Opportunity,' Analyst Says

Shares of Novo Nordisk are down 6% after Q2 results fell short of expectations; weight-loss drug sales disappoint.

Using Weight Loss Medications Such As Wegovy, Zepbound? Psychologist Warns Of Linked Eating Disorder Risks

Psychologists warn of increased eating disorders linked to popular GLP-1 weight loss drugs like Wegovy and Zepbound. Experts urge better screening and research to address potential risks.

What's Going On With HIMS Shares Today?

Hims & Hers Health experienced a significant decline in its stock price on Thursday. Here's what you need to know.

Novo Nordisk's Older Weight Loss Drug May Slow Cognitive Decline in Alzheimer's Patients, Small Study Shows Brain-Protecting Benefits

Liraglutide shows promise in slowing cognitive decline in Alzheimer's patients, reducing brain volume loss and offering neuroprotective benefits, according to a Phase 2b clinical trial presented at AAIC 2024.

Walt Disney, Eli Lilly, AST SpaceMobile, DexCom, Tesla: Why These 5 Stocks Are On Investors' Radars Today

On Thursday, major U.S. indices showed mixed results. The Dow Jones Industrial Average increased by 0.2% to 39,935.07.

UK's NHS Prescribes Weight-Loss Drug Wegovy Less Than Expected Due To Service Shortages

The NHS has prescribed Wegovy far less often than expected due to a shortage of weight management clinics, highlighting significant challenges in meeting growing demand for the weight-loss drug.

Britain's Drug Regulator Approves Novo Nordisk's Weight Loss Drug Wegovy To Cut Heart Disease Risk In Obese Patients

The U.K. MHRA has approved Novo Nordisk's Wegovy (semaglutide) to prevent cardiovascular issues in overweight and obese adults with existing heart conditions. This new indication highlights Wegovy's role in reducing major adverse cardiovascular events by 20%.

Oral Weight Loss Drugs Vs. Injections - Pills Are Promising Yet Challenging Frontier

Pharmaceutical giants like Roche, Eli Lilly, Novo Nordisk, and Pfizer are racing to develop oral weight loss medications. These drugs promise to complement existing injectables, offering new hope in the fight against obesity.

Benzinga

Benzinga

Weight Loss Drugs

Weight Loss Drugs Recent News